Welcome to this week’s Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Kyle LaHucik, and we will feature it here at the end of each week. Pfizer finds dealmaker replacement in McKinsey’s co-U.S. managing partner Aamir Malik to fill COVID-19, M&A shoes […]

It was a busy week for clinical trial news. Here’s a look. COVID-19-Related PureTech Health presented data from the Phase I multiple ascending dose and food effect study of LYT-100. LYT-100 is a deuterated form of pirfenidone, an approved anti-inflammatory and anti-fibrotic drug. It is being developed for inflammatory and fibrotic disease, including lung disease and Long […]

Tampa-based Axogen, a life science company that is developing products for nerve repair, is ramping up hiring for scientists and engineers after navigating through the negative disruptions from the Covid-19 pandemic. Axogen (NASDAQ: AXGN), which works with hospitals in Tampa and St. Pete, has its second HQ in the Tampa Heights building where it currently […]